- Home
- QNCX vs GGR Comparison
QNCX vs GGR Comparison
Compare QNCX & GGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- GGR
- Stock Information
- Founded
- QNCX 2012
- GGR 2011
- Country
- QNCX United States
- GGR Taiwan
- Employees
- QNCX N/A
- GGR N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- GGR Auto Manufacturing
- Sector
- QNCX Health Care
- GGR Consumer Discretionary
- Exchange
- QNCX Nasdaq
- GGR Nasdaq
- Market Cap
- QNCX 90.8M
- GGR 101.1M
- IPO Year
- QNCX 2019
- GGR N/A
- Fundamental
- Price
- QNCX $1.60
- GGR $0.33
- Analyst Decision
- QNCX Strong Buy
- GGR Hold
- Analyst Count
- QNCX 6
- GGR 2
- Target Price
- QNCX $8.00
- GGR $0.50
- AVG Volume (30 Days)
- QNCX 124.9K
- GGR 208.6K
- Earning Date
- QNCX 11-12-2025
- GGR 11-13-2025
- Dividend Yield
- QNCX N/A
- GGR N/A
- EPS Growth
- QNCX N/A
- GGR N/A
- EPS
- QNCX N/A
- GGR N/A
- Revenue
- QNCX N/A
- GGR $289,420,000.00
- Revenue This Year
- QNCX N/A
- GGR N/A
- Revenue Next Year
- QNCX N/A
- GGR $5.00
- P/E Ratio
- QNCX N/A
- GGR N/A
- Revenue Growth
- QNCX N/A
- GGR N/A
- 52 Week Low
- QNCX $0.69
- GGR $0.19
- 52 Week High
- QNCX $2.45
- GGR $1.05
- Technical
- Relative Strength Index (RSI)
- QNCX 47.89
- GGR 41.10
- Support Level
- QNCX $1.56
- GGR $0.34
- Resistance Level
- QNCX $1.65
- GGR $0.36
- Average True Range (ATR)
- QNCX 0.08
- GGR 0.02
- MACD
- QNCX 0.00
- GGR -0.00
- Stochastic Oscillator
- QNCX 64.65
- GGR 14.29
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About GGR Gogoro Inc.
Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.